Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$13.48 - $15.86 $1,348 - $1,586
-100 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$10.8 - $14.6 $37,724 - $50,997
-3,493 Reduced 97.22%
100 $1,000
Q2 2019

Aug 14, 2019

SELL
$10.68 - $14.55 $18,262 - $24,880
-1,710 Reduced 32.25%
3,593 $47,000
Q1 2019

May 15, 2019

SELL
$12.54 - $16.12 $49,144 - $63,174
-3,919 Reduced 42.5%
5,303 $76,000
Q4 2018

Feb 14, 2019

BUY
$10.06 - $14.87 $82,713 - $122,261
8,222 Added 822.2%
9,222 $122,000
Q3 2018

Nov 14, 2018

BUY
$6.33 - $13.02 $6,330 - $13,020
1,000 New
1,000 $11,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $127M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.